Rifaximin prevents overt hepatic encephalopathy after TIPS
Covid-19 vaccination: the dangers of “values” imperialism
2 February 2021Biological sensors could help clinicians make decisions for individual patients
2 February 2021Rifaximin prevents overt hepatic encephalopathy after TIPS
For patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt (TIPS) placement, rifaximin used before and after the procedure is associated with a reduced risk for overt hepatic encephalopathy (HE), according to a study published online Feb. 2 in the Annals of Internal Medicine.
